Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,373.94
(
0.05%
)
News Focus
News Focus
Post# of 257300
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

iandy

Send PM Follow Ignore
Followers 18
Posts 3165
Boards Moderated 0
Alias Born 06/09/2010

iandy

Re: DewDiligence post# 120655

Friday, 05/27/2011 7:54:18 AM

Friday, May 27, 2011 7:54:18 AM

Post# of 257300
>On JNJ’s Investor Day webcast yesterday, Husseini Manji (head of neuroscience) said the phase-2 Bapineuzumab data were reanalyzed by “eliminating the assumption of linearity,” and the reanalysis gave the company greater confidence that the phase-3 program will succeed. I’m not sure what he meant.<

I am guessing he was refering to a reanalysis of the data eliminating the outliers.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today